Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas. - Wikidata - wikimedia - TriplyDB

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

http://www.wikidata.org/entity/Q34501005

about

Efficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.

P2860

Q34392159-CB06F322-0BCC-4276-BBEF-4709D9B9CE33

P2860

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

http://www.wikidata.org/entity/Q34501005

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@ast

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@en

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@nl

type

label

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@ast

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@en

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@nl

prefLabel

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@ast

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@en

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@nl

P1433

Q34501005-5F0F4D7B-6385-40F4-BCFB-860E4A0DD25A

P1476

Q34501005-CFEF3B34-3C19-4555-8CFD-2FB99C9D832B

P2093

Q34501005-219BFB45-6BE7-467E-9D69-75A73CDECDAE

Q34501005-232D4737-BB72-4CAC-BA83-088464DBA591

Q34501005-2B7F4519-EDC6-432D-A438-51BDC2BA48BE

Q34501005-35B7A46B-9258-4C7F-8677-91518F83C497

Q34501005-949F97B4-F9D3-40E6-846F-109C043B3786

Q34501005-A15839F2-29C2-46DA-ACF4-252A85240671

Q34501005-A1EBE99B-C250-4D49-8CEC-79AEE1FFB71C

Q34501005-E7894DFC-5504-4C0D-8A65-0158CED24550

Q34501005-ED0A5C2E-3AA8-4B65-B88D-8C99F7B26B65

Q34501005-FDE0256F-56BB-4B99-906D-698495379334

P2860

Q34501005-03D8F683-8E0A-4725-AE5F-A56ABF206BC5

Q34501005-0B83139F-AECB-4BFD-8C54-16F5D2E60503

Q34501005-2519A33C-175F-4E1A-AFAD-EAE077A47F41

Q34501005-27DC83E2-47E1-4CA8-8DB3-48941D094D7A

Q34501005-34E61F74-6F7F-4A3B-9FF3-8534DD4F0B6D

Q34501005-48EAFF21-7544-4941-9C38-11BAA3C016A7

Q34501005-505A75FB-264E-4DE4-97C4-FFA6ADE1D28D

Q34501005-560B3A10-5978-4FBB-8821-AD71B8D7DD8C

Q34501005-600A8E75-C8A6-468E-9261-F07A0D69A9A4

Q34501005-634E900E-C92F-4370-9F89-4C91FA79CA2E

P304

Q34501005-99EAA610-1911-4ECC-9B14-C89A1D8352C8

P31

Q34501005-D41395FC-FFEC-43C2-B38A-6C57E0ABE4E0

P356

Q34501005-283A44B2-CFF1-4EDA-BD22-0E466F922C97

P478

Q34501005-BD66E005-AE3E-4AFD-9EAB-A1FA65491866

P50

Q34501005-767FD9A6-7746-48F7-A860-B7AECC860843

P577

Q34501005-AB441E02-4A5B-43F4-9C00-27DCD88D21EA

P5875

Q34501005-0C23203C-8901-4035-A700-82EF19078FEB

P698

Q34501005-EEE8C63C-939F-463D-8C65-11EB4DAF7229

P932

Q34501005-D602724C-6FD1-44AD-9BE1-B2DA5CC69E5D

P356

P1433

Advances in Hematology

P1476

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

@en

P2093

Alessandro Spina

http://www.w3.org/2001/XMLSchema#string

Annamaria Giordano

http://www.w3.org/2001/XMLSchema#string

Clara De' Risi

http://www.w3.org/2001/XMLSchema#string

Domenico Pastore

http://www.w3.org/2001/XMLSchema#string

Francesco Gaudio

http://www.w3.org/2001/XMLSchema#string

Mario Delia

http://www.w3.org/2001/XMLSchema#string

Paola Curci

http://www.w3.org/2001/XMLSchema#string

Tommasina Perrone

http://www.w3.org/2001/XMLSchema#string

Vincenzo Liso

http://www.w3.org/2001/XMLSchema#string

Vincenzo Pavone

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Hodgkin disease: prognostic factors and treatment strategies.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Late relapse after treatment for clinical stage I and II Hodgkin's disease.

Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

P304

707542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/707542

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

Giorgina Specchia

P577

2010-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49772975

http://www.w3.org/2001/XMLSchema#string

P698

21253449

http://www.w3.org/2001/XMLSchema#string

P932

3023035

http://www.w3.org/2001/XMLSchema#string